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ABSTRACT 
 Microcirculatory abnormalities havebeen shown to be frequent in patients with septic shock 
despite “normalization”of systemic hemodynamics. Several studies have exploredthe impact of 
vasodilator therapy (prostacyclin, inhaled nitric oxide, topic acetylcholine and nitroglycerin) on 
microcirculation and tissue perfusion, with contradictory findings. 
 In this narrative review, we briefly present the pathophysiologicalaspects of 
microcirculatory dysfunction,and depict the evidence supporting the use of vasodilators and other 
therapeutic interventions (fluid administration, blood transfusion, vasopressors and dobutamine) 
aiming to improve the microcirculatory flowin septic shock patients. 
 
KEY WORDS: sepsis,septic shock, microcirculation, vasodilator agents, nitroglycerin, nitric 
oxide, resuscitation, multiple organ failure. 
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INTRODUCTION 
 Microcirculation is composed of small vessels such as arterioles, capillaries and venules, 
with a diameter lower than 100 μm (1). In fact, the small vessels (diameter ≤20-25 μm), i.e., 
capillaries and postcapillary venules, represent the primary site of oxygen exchange between red 
blood cells (RBC) and tissue cells(1).Microcirculatory blood flow is markedly disturbedin sepsis (2-
4) with a clear association between persistent microcirculatory abnormalities, increased morbidity 
and poor outcomes(5).Therefore, it has been postulated that interventions aiming to 
recruitmicrocirculation, i.e., open non-perfused or intermittentlyperfusedcapillariesmight improve 
tissue perfusion, mitigating the progression to organ failure and death (6). 
According to Poiseuille’s law, blood flow through the capillaries is proportional to the 
pressure gradient between post-arteriolar and venular pressures (microcirculatory driving pressure) 
and the fourth power of the radius, and inversely proportional to capillary length and blood 
viscosity (Figure 1). Therefore, whilst the systemic perfusion pressure is determined by the 
difference between mean arterial blood pressure (MAP) and central venous pressure (CVP), the 
perfusion pressure in the microcirculation (microcirculatory driving pressure) is the net result of 
precapillary inflow pressure (approximately 30 mm Hg) minus venular outflow 
pressure(approximately 10 mm Hg) (Figure 2) (7-9). 
Theoretically, the administration of vasodilating agents, such as acetylcholine (2), nitric 
oxide (NO) donors (10) and nitroglycerin (11)might improve microcirculatory blood flow by 
increasing the precapillary inflow pressure while the venular outflow pressure is maintained, i.e., by 
increasing the microcirculatory driving pressure (Figure 2)(8,9). 
The use of vasodilators as adjuvant therapy in the treatment of circulatory shock was 
introduced into clinical practice in the 1960s (12-14). Nevertheless, the concept supporting 
vasodilators use to optimize microcirculatory perfusion in critical ill patients was only tested in the 
1990s. These studies suggested that different vasodilators, such as prostacyclin (15) and inhaled 
NO(16) might improve splanchnic perfusion. In the past years, several studies have exploredthe 
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impact vasodilators(prostacyclin, inhaled nitric oxide, topic acetylcholine and nitroglycerin) on 
microcirculation and tissue perfusion with contradicting findings. 
 In this narrative review, we briefly presentthe pathophysiology of microcirculatory 
dysfunction,and depict the evidence supporting the use of vasodilators and other therapeutic 
interventions (fluid administration, blood transfusion, vasopressors and dobutamine) aiming to 
improve the microcirculatory flowinseptic shock patients. 
 
MECHANISMS PROMOTING MICROVASCULAR DYSFUNCTION 
 Blood flow through thecapillary network is tightly controlledby the arteriolar resistance 
vessels - the arteriolar network (17,18).Arterioles are surrounded bya smooth muscle layer, which 
cancontract or relaxin response to tissue oxygen tension and the presence of vasoactive agents, such 
as acetylcholine, catecholamines, prostaglandins, endothelin, bradykinin, thromboxane and NO(19). 
Microcirculation perfusion is regulated by an intricate interplay of neuroendocrine, paracrine, and 
mechanosensory pathways (20). These mechanisms control oxygen delivery to the tissues according 
to the cellular metabolic demand(17,21).Under physiologicalconditions, NO acts 
asendogenousvasodilator and the endothelium regulates blood flow to the tissues by “recruiting 
microvessels”through NOrelease(22). In sepsis, theNO system becomesseverelydisturbeddue to a 
heterogeneousexpression of the induciblenitric oxidesynthase(iNOS)(23).Moreover, NO can also be 
consumed by reactive oxygen species (ROS), producing localized areas of relative NO deficiency in 
the microvascular bed(24).This might explain, at least in part,the pathologic heterogeneity of 
microvascular blood flow observed in both experimental (25)and human sepsis(3).  
The relationship between circulating cells and endothelial surface cells is crucial in sepsis 
pathophysiology(26). Glycocalyx is a thin layer of glycosaminoglycan that covers the endothelial 
surface and has the function of facilitating RBC, white blood cells and plateletsflow through the 
capillaries(27). During sepsis, glycocalyx layer thickness is reduced (27), thus increasing leukocytes 
and platelets adhesion to the endothelial cells, and promoting endothelial dysfunction(28).Finally, 
Copyright © 2016 by the Shock Society. Unauthorized reproduction of this article is prohibited.
 
 
decreased RBC rheology(29,30), increased blood viscosity (31), increased number of activated 
neutrophils (32), activation of coagulation and complement systems with fibrin deposition inthe 
microvascular bed (33), along with derangements ofvascular autoregulatory mechanisms 
(34),represent mechanisms that further compromise microcirculation and oxygen delivery in septic 
shock. 
 
MICROCIRCULATION IN SEPTIC SHOCK 
 De Backer and colleagues published the first study addressing the sublingual 
microcirculation in septic shock patients with orthogonal polarization spectral imaging (OPS) in 
2002(2). Their findings were confirmed by several other authors (4,35), demonstrating that 
microcirculatory abnormalities in septic shock are more pronounced in small vessels, i.e., capillaries 
(2), and do not improve over time in non-survivors (5). 
Microcirculatory abnormalities in septic shock arecharacterized by a decrease in total vessel 
density (TVD) and perfused capillary density (PVD) - a surrogate of functional capillary density, as 
well as a decrease inproportion of perfused capillaries (PPV)(2). At the same time, the proportion of 
non-perfused and intermittently perfused capillaries increased (2),along with theflow heterogeneity 
within areas in the same organ separated by few millimeters (3,11,36). Furthermore, capillaries that 
do not exhibit blood flow at a given time can become perfused few seconds or minutes later, 
demonstrating the dynamic behavior of microcirculation under septic conditions (6). 
Additionally, it was demonstrated in twenty-six severe sepsis and septic shock patients 
during the first six hours of resuscitation that microvascular blood flow (microvascular flow index; 
MFI) was slower and more heterogeneous (flow heterogeneity index; FHI) in non-survivals 
compared to survivals (3). These data are in agreement with findings reported by Trzeciak and 
colleagues, who demonstrated that septic shock patients who improved their sequential organ 
failure assessment (SOFA) score during the first 24 hours of resuscitationexhibited a higher 
improvement inmicrovascular blood flow (MFI) compared to patients who did not improve their 
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SOFA score (37). Finally, it was demonstrated that PPV was independently associated with ICU 
survival in severe sepsis and septic shock patients (4). 
These observations led to a growing interest in monitoring microcirculation as a valuable 
adjunct to standard global parameters to predict or diagnose ongoing tissue hypoperfusion(1). 
Indeed, many studies, particularly on sepsis, have highlighted the importance of clinical evaluation 
of microcirculation as part of tissue perfusion monitoring in shock(6). As a result, many authors 
have advocated that therapeutic interventions aiming to improve microcirculation would boost 
tissue perfusion and, consequently, mitigate the progression towards organ failure and death in 
septic shock patients (6,21). 
 
VASODILATORS AND THEIR EFFECTS IN MICROCIRCULATION 
 The concept ofusing pharmacotherapyto optimize the microcirculatory bloodflowin 
critically ill patientsgained notorietyin the late 1980s, when clinical trials addressing the effects of 
drugs withvasodilationproperties such as prostacyclin(38) and dobutamine were 
published(39).Afterwards, several studies have exploredthe impact of vasodilating agents such as 
prostacyclin, inhaled NO, topic acetylcholine and nitroglycerin in microcirculation, tissue perfusion, 
organ function and mortality (table 1). 
 The effect of vasodilator therapy in clinical sepsis was first demonstrated with the use of 
topical nitroglycerin in postoperative patients complicated by severe sepsisresulting in improvement 
in cardiac output (CO) and oxygen consumption (40). More recently, it has been demonstrated that 
administration of vasodilating agents, such as acetylcholine (2) or NO donors (10) was effective in 
recruiting capillaries of sublingual microcirculation in clinical and experimental sepsis. These 
observations had important implications, indicating that microvascular derangements could be 
reversed with drugs (2). Therefore, strategies aiming to open microcirculation through systemic 
vasodilators became a target for new studies(6) (table 1). 
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Pittet and colleagues demonstrated in a small crossover study that by increasing systemic 
oxygen delivery (DO2) through a 30-min intravenousinfusion of prostacyclin, there was an increase 
in systemic oxygen consumption (VO2)and skin microvascular blood flow (41).In another small 
non-controlled study, continuous intravenously prostacyclin infusion up to 32 days, enhanced 
gastric mucosal pH (pHi), suggesting animproved splanchnic blood flow (15).Similar findings were 
demonstrated by Eichelbrönner and colleagues, who reported that aerosolized prostacyclin was 
effective in increase pHi and reducearterial-gastric mucosal pressure of carbon dioxide difference 
(PCO2 gap), while hepatic blood flow, systemic hemodynamics, DO2 and VO2 were not affected 
(42).  
After the development of OPS imaging, it was demonstrated that topic acetylcholine applied 
to the sublingual region, improved microvascular blood flow in septic shock patients (2,43). By 
proving the “recruitable” aspect of microcirculation, Spronk and colleagues demonstrated in a 
prospective open label trial that intravenously nitroglycerin (0.5 mg loading dose followed by a 
continuous infusion of 0.5 to 4.0 mg/h) improved microvascular flow in fluid resuscitated septic 
shock patients (11). 
Following this initial report, Boerma and colleagues randomized 70 fluid resuscitated severe 
sepsis and septic shock patients to receive either intravenously nitroglycerin (2 mg bolus in 30 min 
followed by 2 mg /h up to 24 hours) or placebo (0.9%saline) (44). The authors reported a similar 
improvement in sublingual capillary blood flow during the study period (up to 24 hours) in both 
groups (44). An interesting finding presented in this trial was the lower number of organ 
dysfunctions in patients who received nitroglycerin compared to the placebo group (44).  
More recently, Lima and colleagues demonstrated that a stepwise increase in nitroglycerin 
infusion (starting from 2 mg/h up to 16 mg/h) improved peripheral perfusion in circulatory shock 
patients who persisted with abnormal peripheral perfusion after six hours of resuscitationdespite 
achieving macrohemodynamic stabilization (45). Finally, Trzeciak and colleagues randomized 49 
septic shock patients to receive either inhaled NO (40 ppm) or sham inhaled NO (placebo) for six 
Copyright © 2016 by the Shock Society. Unauthorized reproduction of this article is prohibited.
 
 
hours starting after the achievement of conventional macrohemodynamic goals (MAP ≥65 mmHg, 
central venous oxygen saturation (ScvO2) ≥70 % or lactate clearance ≥10%) (46). The authors 
reported no differences between the groups regarding microcirculatory flow or in-hospital mortality 
(46).  
 
OTHER THERAPIES THAT MAY IMPROVE MICROCIRCULATION IN SEPTIC 
SHOCK 
 
Fluid therapy 
 The main determinants of oxygen transport to the tissue cells are convection (convective 
transport of oxygen carrying RBC through capillaries) and diffusion (diffusion of oxygen from 
RBC to tissue cells mitochondria) (Figure 3) (47). Convective flow is determined by the product of 
the rate at which RBC enter the capillaries (RBC/seconds), the RBC oxygen saturation (HbSat) and 
the oxygen-carrying capacity of a RBC at 100% of saturation (0.0362 pl O2/RBC)(47). Oxygen 
diffusion from the capillary RBC to the tissue cells mitochondria is determined by Fick’s law of 
diffusion. Accordingly, oxygen diffusion is the product of the oxygen gradient from RBC to 
mitochondria (pO2Grad) and the diffusion coefficient (D) times the exchange surface (S) divided by 
the diffusion distance (d) from the RBC to the mitochondria(47). 
 Therefore, fluid administration can improve microcirculatory blood flow by improving the 
convective transport of oxygen(47). Furthermore, blood flow through capillaries is proportional to 
the driving pressure across the capillary and by the fourth power of the radius, and inversely 
proportional to capillary length and blood viscosity. Thus, volume expansion may also improve 
microvascular blood flow by increasing the driving pressure in microcirculation, decreasing blood 
viscosity as well as by decreasing the release of endogenous vasoconstrictors (increasing vessels 
radius) (6). 
Copyright © 2016 by the Shock Society. Unauthorized reproduction of this article is prohibited.
 
 
 On the other hand, fluid overload may affect microcirculation by increasing venular outflow 
pressure (boost venous return) and, therefore, by decreasing microcirculatory driving pressure 
(convection) and/or by increasing diffusion distance (diffusion) between capillary RBC and tissue 
mitochondria (Figure 3) (48). 
Two observational studies demonstrated that timely fluid administration could improve 
microvascular perfusion (49,50). Ospina-Tascon and colleagues investigated 60 hypovolemic 
severe sepsis patients requiring volume expansion within 24 hours (early) or after 48 hours(late) of 
sepsis recognition (49). The authors demonstrated that volume expansion with Ringer Lactate or 4% 
albuminimproved capillary blood flow only in early sepsiswhereaslatefluid administration failed to 
improve microcirculation despite having increasedCO and MAP(49).Fluid administration did not 
affect flow heterogeneity in either early or late sepsis (49). 
Moreover, it was demonstrated that both passive leg raising and volume expansionwith 500 
ml of 0.9% saline or 6% hydroxyethyl starch (130/0.4) improved sublingual microcirculatory 
parametersand decreased flow heterogeneityregardless the type of fluid in preload-responsive 
severe sepsis and septic shock patients within the first 24 hours of intensive care unit (ICU) 
admission (50).Interestingly, improvements in microcirculation perfusion after volume expansion 
either by passive leg raising or volume expansion do not seem to be related to RBC rheologyas 
hemoglobin levels remained constant during the study procedures (50).  
 
Dobutamine and vasopressors 
Dobutamine is primarily beta-adrenergic agent, but it also has mild 
vasodilatoryeffects(51).Thus, dobutamine administration may improve microvascular blood flow by 
increasing microcirculatory driving pressure (Figure 2) and by increasing cardiac output 
(convective transport of oxygen).   
Few studies evaluated the effects of dobutamine on the microcirculationof critically ill 
patients (43,52,53).Initial studies suggested that dobutamine could increase skin microvascular 
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(52)and gastric mucosal blood flow (53,54).In a prospective open label studywith 22 septic shock 
patients (<48 hours of onset), De Backer and colleagues demonstrated that dobutamine infusion (5 
mcg/kg/h during 2 hours) improve capillary blood flow(43). Interestingly, changes in capillary 
perfusion did not correlate with changes in systemic hemodynamics (cardiac index, MAP or 
systemic vascular resistance), but were inverselycorrelated with changes in arterial lactate 
levels(43). 
The effects of different MAP targets on microcirculation and tissue perfusion in septic shock 
patients were recently revised elsewhere(55). The impact of increasing MAP from 65 mmHg to 85 
mmHg on microcirculatory blood flow was prospectively evaluated in twenty fluid resuscitated 
septic shock patients(56). In this study, increasing MAP with escalating doses of 
norepinephrinefailed to improvemicrovascular blood flow in small, medium and large vessels (56). 
Similar findings were reported by Jhanji and colleagues, who demonstrated that escalating doses of 
norepinephrine aiming to increase MAP from 60 to 70, 80, and 90 mmHg, respectively, had no 
effects on sublingual microvascular blood flow in septic shock patients (57).  
 
Red blood cells transfusion 
 It was demonstrated in a prospective observational study with 35 severe sepsis and septic 
shock patients that anincrease in hemoglobin concentration from 7.1 g/dL to 8.1 g/dL through a 
leukocyte-reducedRBC transfusion,failed to improvesublingual microcirculation despite improving 
DO2(58). Similar findings were reported by Sadaka and colleagues, who demonstrated that an 
increase on hemoglobin concentration from approximately 7.2 g/dL to 8.8 g/dL through one non-
leukoreduced packed RBC transfusion during the first 12 hours of sepsis did not affect sublingual 
microcirculation and thenar tissue oxygen saturation (StO2) (59). Finally, whether non-
leukodepleted or leukodepleted RBC transfusion affects the microvascular perfusion in septic 
patients and whether microcirculation analysis is useful to guide RBC transfusion need to be further 
investigated (60). 
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FUTURE DIRECTIONS 
 Microcirculation analysis in critically ill patients is an evolving issue (1).The development 
of new user-friendly devices to assess microcirculation at the bedside along with a rapid, online, 
operator independent, and automated image analysis will allow researchers to exploretherapies 
targeting microcirculation during the early phases of septic shock resuscitation more easily and 
quickly (61,62).  
 Recently, a third generation of handheld microscope, based on Incident Dark Field 
illumination (IDF) (CytoCam; Braedius Medical BV, Huizen, The Netherlands),along with an 
automatized analysis software (CytoCamTools V1; Braedius Medical BV, Huizen, The 
Netherlands)have been launched(61).The CytoCam-IDF imaging provides a better image quality in 
terms of contrast and image sharpness and has proved effective in detecting 30% more capillaries in 
health volunteers than Sidestream Dark Field imaging (SDF) due to improved magnification lens 
and a high-resolution sensor (61). Nevertheless, the accuracyof this new automatized analysis 
software to detect microvascular abnormalities in septic shock patientsneeds to be addressed (63). 
  
 Finally, so far, no study has evaluated if targeting microcirculation during a quantitative 
resuscitation algorithm would affect outcomes in septic shock patients. Therefore, new and well-
designed studies, adequately powered, addressing the impact of such resuscitation strategy on 
patient centered outcomes are needed.  
 
CONCLUSIONS 
 While normalization of macrohemodynamic parameters remains a concern in septic shock 
resuscitation, it wasclearly demonstrated that such parameters poorly reflect the microcirculation 
condition.Moreover, microcirculatory derangements are frequent in septic shock patients and have 
been associated with increased morbidity and mortality. Therefore, additional efforts aiming to 
improve microcirculation,such as intravenousvasodilators administration, have been advocated. 
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However, the impact of such interventions on patient-centered outcomes need to be further verified 
throughwell-designed randomized controlled clinical trials. 
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Figure 1.Figure 1. The main determinants of the microcirculatory blood flow 
accordingly to the Poiseuille’s law. 
 
Blood flow through the capillaries (Q) is proportional to the pressure gradient between 
post-arteriolar (P1) and venular pressures (P2), i.e., the microcirculatory driving 
pressure (P1-P2), and by the fourth power of the capillary radius (r4), and is inversely 
proportional to capillary length (L) and blood viscosity (µ). The black arrows represent 
the blood flow direction through microvessels. RBC: red blood cells. 
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Figure 2. The effect of vasodilators on the microcirculatory driving pressure and on the 
microcirculatory blood flow. 
 
A: systemic perfusion pressure (difference between mean arterial blood pressure and 
central venous pressure), B: microcirculatory driving pressure (precapillary inflow 
pressure minus venular outflow pressure) and C: theoretical effect of a vasodilating 
administration improving microcirculatory blood flow by increasing the precapillary 
inflow pressure while the venular outflow pressure is maintained (increased 
microcirculatory driving pressure). Modified from (23) with permission. 
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Figure 3. The effects of fluid overload on microcirculatory blood flow. 
 
Convective flow is determined by the product of the rate at which red blood cells (RBC) 
enter the capillaries, the RBC oxygen saturation and the oxygen-carrying capacity of a 
RBC at 100% of saturation. Oxygen diffusion from capillary RBC to tissue cell 
mitochondria is determined by the product of the oxygen gradient from RBC to 
mitochondria and the diffusion coefficient, times the exchange surface divided by the 
diffusion distance (d1 and d2) from RBC to mitochondria. Panel A: Blood flow though 
microcirculation under normovolemic conditions. Panel B: impaired convection (due to 
increased venular outflow pressure) and diffusion [increased diffusion distance (d2) 
between capillary RBC and tissue cells mitochondria]. 
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Table 1:Studies addressing the efficacy and safety of vasodilating agents in septic patients. 
First Author; year n Vasodilator Site Device Main study findings Type of study 
Pittet J-F, 1990 (41) 11 
I.V. prostacyclin 
vs.  
I.V. 
phentolamine  
Skin (inner 
thigh) 
Laser 
Doppler 
flowmeter 
Higher improvement in skin 
microvascular blood flow with 
prostacyclin infusion than with 
phentolamine. 
Prospective, 
interventional, 
randomized 
Radermacher P, 1995 
(15) 16 I.V. prostacyclin 
Splanchnic 
(Gastric) 
Gastric 
Tonometry 
Prostacyclin infusion increased pHi with 
concomitant increase in DO2. Oxygen 
consumption remained unchanged. 
Prospective, 
interventional,  
non-controlled 
Eichelbrönner O, 1996 
(42) 16 
Aerosolized 
prostacyclin vs. 
inhaled NO 
Splanchnic 
(Gastric) 
Splanchnic 
(Gastric) 
 
Only aerosolized prostacyclin increased 
pHi and reduced PCO2 gap. Hepatic 
blood flow (Indocyanine-green plasma 
disappearance rate) remained unchanged. 
Prospective, 
interventional, 
randomized 
De Backer D, 2002 (2) 11 Topic acetylcholine 
Sublingual 
microcirculation OPSimaging Increased  TVD and PPV (capillaries)  
Prospective, 
interventional, 
non-randomized, 
non-controlled  
De Backer D, 2006 (43) 10 
Topic 
acetylcholine + 
dobutamine (5 
mcg/kg/min) 
Sublingual 
microcirculation OPS imaging 
Increased  TVD, PPV and PVD 
(capillaries) 
Prospective, 
interventional, 
non-randomized, 
non-controlled 
Spronk PE, 2002 (11) 8 I.V. nitroglycerin 
Sublingual 
microcirculation OPS imaging Improved capillary MFI 
Prospective, 
interventional, 
non-controlled, 
open-label 
Boerma EC, 2010 (44) 70 
I.V. 
nitroglycerin 
vs. placebo 
Sublingual 
microcirculation SDF imaging 
No differences after 24 hours of 
nitroglycerin or placebo regarding (small 
vessels) MFI, TVD, PPV, PVD and FHI  
Prospective, 
placebo 
controlled, 
double-bind study  
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Lima A, 2014(45) 15* I.V. nitroglycerin Skin 
Pulse 
oximeter, 
NIRS 
Increased CRT, PPI, StO2 and 
ReO2whileTskin-diff decreased.  
Prospective,  
interventional, 
non-controlled 
study 
Trzeciak S, 2014 (46) 49 Inhaled NO vs. placebo 
Sublingual 
microcirculation SDF imaging 
No differences after 2 hours of Inhaled 
NO or placebo on MFI and FHI 
Prospective, 
placebo 
controlled, 
double-bind study 
Legend:OPS: orthogonal polarization spectral, SDF: sidestream dark field imaging, pHi:gastric mucosal pH, PCO2 gap: arterial-gastricmucosal 
pressure of carbon dioxidegap difference, TVD:total vessel density, PPV:proportion of perfusedvessels, PVD: perfused vesseldensity, 
MFI:microvascular flow index, FHI:flow heterogeneity index, CRT: capillary refill time, Tskin-diff:forearm-to-fingertip skin temperature 
difference, PPI:peripheral perfusion index, StO2: tissue oxygen saturation, NIRS:near-infrared spectroscopy, ReO2:peripheral tissue 
reoxygenation rate after arterial occlusion test. *:Twelve out of 15 patients included had septic shock. 
